• Buy 1 Get 1 FREE for immortalized cells| limited time until end of June

  • Boost Your Research with FREE Freezing Medium

Primary Cells

Human PB CD8+/CD45RA+ Naïve Cytotoxic T Cells

  • For research use only

Cat No.

ABC-TC4006

Product Type

Immune Cells

Cell Type

T Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Normal

Storage

Liquid Nitrogen

Human PB CD8+/CD45RA+ Naïve Cytotoxic T Cells enable reliable investigation of naive CTL responses in immune monitoring and immunotherapy development.

Product Image

Description

Human PB CD8+/CD45RA+ Naïve Cytotoxic T Cells are isolated from peripheral blood mononuclear cells. This process yields a highly purified population of CD8+/CD45RA+ naïve cytotoxic T cells. After primary culture, the cells are cryopreserved. These cells are characterized by CD8 expression, indicating their cytotoxic potential, and CD45RA expression, marking their naïve, undifferentiated state. They are crucial for adaptive immune responses against intracellular pathogens such as viruses and tumor cells. These cells exhibit limited proliferative capacity and should be handled gently, avoiding repeated freeze-thaw cycles during in vitro studies. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.

Product Code

Human PB CD8+/CD45RA+ Naïve Cytotoxic T Cells, Naïve CD8+ T Cells (CD45RA+), PB RA+ CTLs, Resting Cytotoxic T Lymphocytes

Species

Human

Cat.No

ABC-TC4006

Product Category

Primary Cells

Size/Quantity

1 vial

Cell Type

T Cell

Growth Mode

Suspension

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Normal

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Immune Cells

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • Human PB CD8+/CD45RA+ Naïve Cytotoxic T Cells can be used to investigate early-stage immune responses, especially in T cell development and activation. These cells serve as a model to study naive T cell priming, differentiation into effector cells, and immune memory formation. They are relevant in immunological studies on vaccination, immune tolerance, and response to pathogens or tumors. Their naïve phenotype enables researchers to examine signaling pathways involved in the initiation of cytotoxic T cell immunity.

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring Human PB CD8+/CD45RA+ Naïve Cytotoxic T Cells

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button